Galera Therapeutics (GRTX) has provided an update.
Galera Therapeutics, Inc. is streamlining its operations amidst a strategic review by eliminating the COO position held by Dr. Robert A. Beardsley to cut costs. Dr. Beardsley is set to receive severance as per his employment agreement, and may continue to provide consulting services to the company. The report includes forward-looking statements, and actual outcomes may vary due to various risks and uncertainties highlighted in the company’s latest annual report.
See more insights into GRTX stock on TipRanks’ Stock Analysis page.
